12 Health Care Stocks Moving In Friday's Intraday Session

Author: Benzinga Insights | February 24, 2023 01:31pm

Gainers

• Cingulate (NASDAQ:CING) stock increased by 49.1% to $1.66 during Friday's regular session. Trading volume for Cingulate's stock is 32.0 million as of 12:30 EST. This is 37225.8% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $18.7 million.
• OncoSec Medical (NASDAQ:ONCS) shares increased by 20.46% to $1.22. OncoSec Medical's stock is trading at a volume of 968.2K shares as of 12:30 EST. This is 132.1% of its average full-day volume over the last 100 days. The company's market cap stands at $3.6 million.
• MultiPlan (NYSE:MPLN) stock moved upwards by 20.23% to $1.08. As of 12:30 EST, this security is trading at a volume of 1.4 million shares, making up 79.7% of its average full-day volume over the last 100 days. The company's market cap stands at $736.3 million.
• ASLAN Pharma (NASDAQ:ASLN) shares rose 15.74% to $0.81. ASLAN Pharma's stock is trading at a volume of 502.6K shares as of 12:30 EST. This is 304.1% of its average full-day volume over the last 100 days. The company's market cap stands at $56.5 million.
• HTG Molecular Diagnostics (NASDAQ:HTGM) shares moved upwards by 13.31% to $3.66. HTG Molecular Diagnostics's stock is trading at a volume of 665.0K shares as of 12:30 EST. This is 41.1% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $3.7 million.
• Celularity (NASDAQ:CELU) stock moved upwards by 13.04% to $0.67. Celularity's stock is trading at a volume of 394.4K shares as of 12:30 EST. This is 65.9% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $97.1 million.

Losers

• SELLAS Life Sciences Gr (NASDAQ:SLS) stock declined by 54.4% to $1.68 during Friday's regular session. As of 12:30 EST, this security is trading at a volume of 4.7 million shares, making up 2821.2% of its average full-day volume over the last 100 days. The company's market cap stands at $34.6 million.
• Fulcrum Therapeutics (NASDAQ:FULC) shares fell 50.08% to $6.43. As of 12:30 EST, this security is trading at a volume of 6.8 million shares, making up 834.1% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $396.8 million.
• Nektar Therapeutics (NASDAQ:NKTR) shares decreased by 46.8% to $1.57. The current volume of 9.9 million shares is 576.6% of Nektar Therapeutics's average full-day volume over the last 100 days (last updated at 12:30 EST). The market value of their outstanding shares is at $296.0 million.
• Inogen (NASDAQ:INGN) shares declined by 32.86% to $15.55. Trading volume for Inogen's stock is 964.7K as of 12:30 EST. This is 552.6% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $356.4 million. As per the press release, Q4 earnings came out yesterday.
• Ambrx Biopharma (NYSE:AMAM) stock fell 26.5% to $4.8. Trading volume for this security as of 12:30 EST is 4.3 million, which is 68.4% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $185.3 million.
• Erytech Pharma (NASDAQ:ERYP) stock declined by 18.91% to $0.73. The company's market cap stands at $22.6 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: AMAM ASLN CELU CING ERYP FULC HTGM INGN MPLN NKTR ONCS SLS